Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
18.15
+0.15 (0.83%)
At close: Jun 26, 2026, 4:00 PM EDT
18.39
+0.24 (1.32%)
After-hours: Jun 26, 2026, 7:27 PM EDT
Trevi Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Trevi Therapeutics stock have an average target of 24.5, with a low estimate of 20 and a high estimate of 30. The average target predicts an increase of 34.99% from the current stock price of 18.15.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 20, 2026.
Analyst Ratings
The average analyst rating for Trevi Therapeutics stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 8 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Maintains $23 | Buy | Maintains | $23 | +26.72% | May 20, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $24 | Buy | Reiterates | $24 | +32.23% | May 8, 2026 |
| Clear Street | Clear Street | Buy Maintains $21 → $29 | Buy | Maintains | $21 → $29 | +59.78% | May 7, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $24 | Buy | Maintains | $24 | +32.23% | May 7, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $18 → $30 | Buy | Reiterates | $18 → $30 | +65.29% | May 6, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.47
from -0.32
EPS Next Year
-0.56
from -0.47
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.47 | -0.56 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.